HUP0200157A2 - A terméketlenség kezelése - Google Patents

A terméketlenség kezelése

Info

Publication number
HUP0200157A2
HUP0200157A2 HU0200157A HUP0200157A HUP0200157A2 HU P0200157 A2 HUP0200157 A2 HU P0200157A2 HU 0200157 A HU0200157 A HU 0200157A HU P0200157 A HUP0200157 A HU P0200157A HU P0200157 A2 HUP0200157 A2 HU P0200157A2
Authority
HU
Hungary
Prior art keywords
infertility
treatment
vitro fertilization
meiosis
activates
Prior art date
Application number
HU0200157A
Other languages
English (en)
Inventor
Christian Grondahl
Thomas Host Hansen
Christa Hegele-Hartung
Alexander Rübig
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of HUP0200157A2 publication Critical patent/HUP0200157A2/hu
Publication of HUP0200157A3 publication Critical patent/HUP0200157A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány emberek in vitro megtermékenyítési eljárására vonatkozik.Az in vitro megtermékenyítés meiózist aktiváló vegyülettel javítható. Ó
HU0200157A 1999-02-24 2000-02-23 Treatment of infertility HUP0200157A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199900255 1999-02-24
US13081699P 1999-04-23 1999-04-23
DKPA199901310 1999-09-16

Publications (2)

Publication Number Publication Date
HUP0200157A2 true HUP0200157A2 (hu) 2002-05-29
HUP0200157A3 HUP0200157A3 (en) 2002-06-28

Family

ID=27220546

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200157A HUP0200157A3 (en) 1999-02-24 2000-02-23 Treatment of infertility

Country Status (13)

Country Link
US (1) US6585982B1 (hu)
EP (1) EP1156822B1 (hu)
JP (1) JP2002537349A (hu)
KR (1) KR20010093280A (hu)
CN (1) CN1353617A (hu)
AT (1) ATE317266T1 (hu)
AU (1) AU2794100A (hu)
BR (1) BR0008468A (hu)
CZ (1) CZ20012967A3 (hu)
DE (1) DE60025905T2 (hu)
ES (1) ES2258445T3 (hu)
HU (1) HUP0200157A3 (hu)
WO (1) WO2000050066A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
KR20020013505A (ko) * 1999-02-26 2002-02-20 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 감수분열활성 스테롤에 의한 착상율의 증가
WO2001062258A2 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate using ff-mas
AU3376501A (en) * 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
MXPA02011271A (es) * 2000-05-18 2003-04-25 Schering Ag Fertilizacion de oocitos envejecidos.
US6995252B2 (en) * 2000-05-25 2006-02-07 Queen's University At Kingston PT32 sperm protein, sperm c-Yes, oocyte cytoplasmic c-Yes and uses thereof
EP1216701A1 (en) * 2000-12-22 2002-06-26 Schering Aktiengesellschaft Process to increase the concentration of meiosis-activating sterols (MAS) in the cholesterol synthesis and the use of potent inhibitors in the process
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
YU21104A (sh) 2001-09-12 2006-08-17 Applied Research Systems Ars Holding N.V. Upotreba hcg i lh u kontrolisanoj hiperstimulaciji ovarijuma
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
EA009330B1 (ru) * 2001-09-12 2007-12-28 Апплайд Резеч Системз Арс Холдинг Н.В. Способ содействия имплантации и/или снижения частоты выкидышей и набор для его осуществления
AU2003203145A1 (en) * 2002-02-22 2003-09-09 Novo Nordisk A/S A transducer of mas signalling
US20050208651A1 (en) 2002-03-08 2005-09-22 Ri-Cheng Chian Vitro maturation of immature human oocytes
NZ536984A (en) * 2002-06-07 2008-01-31 Ares Trading Sa Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
AU2005257839A1 (en) 2004-05-17 2006-01-05 The General Hospital Corporation Methods and compositions for producing germ cells from bone marrow derived germline stem cells
EP2422794A3 (en) 2006-03-07 2013-03-13 Geeta Shroff Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
WO2012142500A2 (en) 2011-04-14 2012-10-18 The General Hospital Corporation Compositions and methods for autologous germline mitochondrial energy transfer
EA201490050A1 (ru) 2011-06-29 2014-07-30 Зе Дженерэл Хоспитэл Корпорейшн Композиции и способы повышения биоэнергетического состояния женских зародышевых клеток
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
AU717180B2 (en) * 1995-03-06 2000-03-16 Novo Nordisk A/S Stimulation of meiosis
RU2182909C2 (ru) * 1995-06-23 2002-05-27 Ново Нордиск А/С Стероиды, способ регулирования мейоза
WO1997000883A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
JP2001506656A (ja) * 1996-12-20 2001-05-22 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
ATE215555T1 (de) * 1997-06-04 2002-04-15 Akzo Nobel Nv 17-beta.-allyloxy(thio)alkyl-androstan derivative zur modulation von meiose
US5866599A (en) * 1997-06-06 1999-02-02 Basf Aktiengesellschaft Fungicidal mixtures
AU2794000A (en) * 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility

Also Published As

Publication number Publication date
JP2002537349A (ja) 2002-11-05
DE60025905D1 (de) 2006-04-20
AU2794100A (en) 2000-09-14
ES2258445T3 (es) 2006-09-01
CZ20012967A3 (cs) 2001-12-12
US6585982B1 (en) 2003-07-01
EP1156822B1 (en) 2006-02-08
DE60025905T2 (de) 2006-09-14
KR20010093280A (ko) 2001-10-27
CN1353617A (zh) 2002-06-12
HUP0200157A3 (en) 2002-06-28
EP1156822A1 (en) 2001-11-28
ATE317266T1 (de) 2006-02-15
BR0008468A (pt) 2002-02-05
WO2000050066A1 (en) 2000-08-31

Similar Documents

Publication Publication Date Title
HUP0200157A2 (hu) A terméketlenség kezelése
UY26249A1 (es) Moléculas pequenas útiles en el tratamiento de las enfermedades inflamatorias ley 17164 art. 127
HN1996000082A (es) Compuestos de quinolina y quinozssolina utiles en terapia.
NO20013444D0 (no) Triazolforbindelser med dopamin-D3-reseptor-affinet
DE69617087D1 (de) Verfahren zum behälterlosen Herstellen rissfreier Gegenstände aus Metall
PT1143967E (pt) Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas
TR199701073T1 (xx) Protein kinaz C inhibit�rleri.
FI972205A0 (fi) cGmp-PDE:n estäjiä erektiohäiriön hoidossa
ATE455106T1 (de) Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
CR6577A (es) Inhibidores triciclicos de poli(adp-ribosa) polimerasas
HN2000000268A (es) Compuestos , composiciones y metodos para estimular el crecimiento y elongacion de neuronas
DE60239558D1 (de) Kombinationen für die behandlung von immun-entzündlichen erkrankungen
ATE413399T1 (de) Morpholinyl-harnstoff-derivative fuer die behandlung von krankheiten verbunden mit entzuendlichen prozessen
AU5173501A (en) Polyamine analogues as cytotoxic agents
DOP2003000621A (es) Inhibidores triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
FI20020835A0 (fi) Menetelmä jalometallirikasteen jalostamiseksi
EP1492902A4 (en) COMPOSITION AND PROCESS FOR TREATING METAL SURFACES
ES2163261T3 (es) Instalacion continua para el tratamiento de piezas de trabajo.
NO20013880D0 (no) Matriks og fremgangsmate for fremstilling av polyolefin
ITBO990363A0 (it) Impianto per la lavorazione di corpi piani .
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
MXPA03011502A (es) Aminoalcoholes sustituidos utiles en tratamiento de enfermedad de alzheimer.
BG104801A (en) Indole-2,3-dione-3-oxime derivatives for therapeutical use
PT1152762E (pt) Utilizacao de desoxipeganina no tratamento da demencia de alzheimer